Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Arrowhead Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
ARWR
Nasdaq
2834
http://arrowheadpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arrowhead Pharmaceuticals Inc
Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock
- Dec 4th, 2019 11:00 am
Edited Transcript of ARWR earnings conference call or presentation 25-Nov-19 9:30pm GMT
- Dec 3rd, 2019 9:58 pm
Where to Buy Booming Biotech ETFs
- Dec 3rd, 2019 2:26 pm
Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar?
- Dec 3rd, 2019 11:55 am
This Highly Rated Biotech Company Just Tumbled 13% On A Public Offering
- Dec 2nd, 2019 9:48 pm
Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock
- Dec 2nd, 2019 9:05 pm
7 Exciting Biotech Stocks to Buy Now
- Dec 2nd, 2019 7:57 pm
This Biotech With 488% Growth In 2019 Just Gained A Price-Target Boost
- Nov 29th, 2019 6:23 pm
Biotech Arrowhead Stock’s Surge Will Continue, Analyst Says
- Nov 29th, 2019 2:52 pm
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
- Nov 28th, 2019 1:07 pm
The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen
- Nov 27th, 2019 12:26 pm
Arrowhead Pharmaceuticals, Inc. Just Missed Earnings And Its EPS Looked Sad - But Analysts Have Updated Their Models
- Nov 27th, 2019 9:55 am
Arrowhead Pharmaceuticals to Participate in Upcoming December 2019 Conferences
- Nov 26th, 2019 9:00 pm
Arrowhead Pharmaceuticals Reports Fiscal Year 2019 Results
- Nov 25th, 2019 9:00 pm
Novartis’s Deal for Medicines Company Is Good News for 2 More Stocks
- Nov 25th, 2019 3:27 pm
Arrowhead Presents New Clinical Data on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3 at AHA Scientific Sessions 2019
- Nov 18th, 2019 2:32 pm
Arrowhead Pharmaceuticals Announces Planned Management Transition
- Nov 15th, 2019 12:30 pm
Arrowhead Shares Are Still Alerting Big Buy Signals
- Nov 13th, 2019 7:12 pm
Scroll